William Simonds is an Endocrinologist in Baltimore, Maryland. Dr. Simonds is rated as an Elite provider by MediFind in the treatment of Milk-Alkali Syndrome. His top areas of expertise are Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Parathyroid Adenoma, Parathyroidectomy, and Thymectomy.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

Sonum Bharill is a Pediatric Endocrinologist in Baltimore, Maryland. Dr. Bharill is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Hypercalcemia, Milk-Alkali Syndrome, Diabetic Ketoacidosis, and Type 1 Diabetes (T1D).

Dr. Sara Mixter is Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are internal medicine, pediatrics, and primary care for adults with developmental disabilities and other complex childhood-onset conditions. She is the director of the Hopkins PACT (Pediatric-informed Adult Care and Transition) Clinic. Dr. Mixter is also the medical director of the Pediatric Complex Care Collaborative (PC3) for the Johns Hopkins Children’s Center. Dr. Mixter received her A.B. from Harvard College. She earned her M.D. from Harvard Medical School and M.P.H. from the Harvard School of Public Health. She completed her residency at Johns Hopkins as part of the inaugural group of trainees in the Urban Health Combined Internal Medicine-Pediatrics Residency Program. Her research interests include transitions of care for adolescents with special healthcare needs and education for residents and medical students, especially in primary care and complex care. Dr. Mixter has served as the Assistant Chief of Service for the Longcope firm of the Osler Medical Housestaff Training Program (2015-16), as well as Assistant Program Director for Ambulatory Education (2014-15). Dr. Mixter is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Cerebral Palsy, Gastroparesis, Orbital Cellulitis, and Sickle Cell Disease.

David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. His top areas of expertise are Thyroid Cancer, Graves Disease, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Dr. Janet L. Crane is an Associate Professor of Pediatrics at the Johns Hopkins University School of Medicine. Dr. Crane is the Director of the Pediatric Bone Health Program, which focuses on the care of children with rare metabolic bone diseases and osteoporosis/skeletal fragility syndromes. Dr. Crane received her bachelor’s degree in nutritional science from the University of Missouri. She completed her medical degree at the University of Maryland-Baltimore, residency in pediatrics at Children's Mercy Hospital and Clinics in Kansas City, Missouri and fellowship in pediatric endocrinology at Johns Hopkins University in 2013. Dr. Crane is a faculty member of the Center for Musculoskeletal Research. Her research is focused on bone modeling and remodeling factors that result in proper bone growth and strength. The goal of her studies is to identify diagnostic markers and therapeutic targets to enhance bone strength in children who have recurrent fractures. Dr. Crane also participates in industry sponosored clinical studies to investigate the safety and efficacy of medications for metabolic bone disease and skeletal fragility. Dr. Crane is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Osteogenesis Imperfecta, Juvenile Primary Osteoporosis, Short Stature (Growth Disorders), and Noonan Syndrome.

Dr. Malinda Wu is a pediatric endocrinologist seeing patients at the Johns Hopkins Children’s Center in Baltimore, Maryland. She specializes in a wide range of pediatric endocrine conditions including metabolic bone disease, pediatric osteoporosis and cystic fibrosis endocrinopathies. Dr. Wu received her M.D. from Jefferson Medical College, Thomas Jefferson University. She completed pediatrics residency at Penn State Hershey Medical Center and her pediatric endocrine fellowship at Emory University School of Medicine. She received her Master of Science in Clinical Research from Emory University (2021). Dr. Wu has been a faculty member at Johns Hopkins since 2021. Dr. Wu’s research interests are in metabolic bone disease and the health of women with cystic fibrosis. Dr. Wu’s current research is focused on women with cystic fibrosis and how estrogen supplementation may impact their health. She has received grant funding from the Cystic Fibrosis Foundation. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Osteogenesis Imperfecta, Hypogonadism, Malnutrition, Exocrine Pancreatic Insufficiency, and Hormone Replacement Therapy (HRT).

Amal Hassan Ahmed Awadalla, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Faculty of Medicine University of Khartoum, and completed her residency at Queens Hospital Center. Dr. Awadalla is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Neurosarcoidosis, and Sarcoidosis.

Dr. Mohamad Hanouneh is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Hanouneh grew up in Syria and completed his medical school in Tishreen University in Latakia, Syria. He completed Internal Medicine Residency training at Cleveland Clinic, and Nephrology Fellowship at Johns Hopkins. Dr. Hanouneh currently serves as a part-time faculty in the Division of Nephrology at Johns Hopkins. He also works in the Nephrology Center of Maryland covering Good Samaritan and Upper Chesapeake Hospitals. Dr. Hanouneh has a passion in medical education. He runs the nephrology board review course and participates in Genes to Society Course of Renal Physiology, which is given to the medical students at Johns Hopkins University School of Medicine. His area of interests are electrolytes disorders, diabetic kidney disease and nephrolithiasis. Dr. Hanouneh is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. His top areas of expertise are Low Potassium Level, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and High Potassium Level.

Colleen Leavitt, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians. She received her medical degree and completed her residency in medicine & pediatrics at Loyola University School of Medicine. Dr. Leavitt is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. His top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Dr. Kendall Moseley is the Clinical Director of the Division of Diabetes, Endocrinology & Metabolism, Medical Director of the Johns Hopkins Metabolic Bone & Osteoporosis Center and Co-Director of the Johns Hopkins Multidisciplinary Parathyroid Clinic. Dr. Moseley received her medical degree from Baylor College of Medicine in Houston, TX, followed by internal medicine residency training at the Johns Hopkins Hospital. Upon completion of her endocrinology fellowship at Johns Hopkins, she joined the faculty in the Division of Endocrinology, Diabetes & Metabolism of the Johns Hopkins University School of Medicine. Dr. Moseley has a dynamic clinical practice and collaborations within the institution that focus on metabolic bone diseases, osteoporosis, hyperparathyroidism, vitamin D deficiency, atypical fractures, and skeletal survivorship. She is actively engaged in NIH-funded clinical and translational research involving the relationship between type 2 diabetes, osteoporosis, and aging. She is additionally involved in research investigating mechanisms by which chronic disease states such as malignancy, HIV, hepatitis C, and cystic fibrosis impact bone quantity and quality. Clinically, she enjoys partnering with her patients and using their unique and often complex medical history to individually tailor effective diet, lifestyle, and treatment regimens to improve skeletal health. Dr. Moseley is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Paget's Disease of Bone, and Hyperparathyroidism.

Dr. Bernard Jaar is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include chronic kidney disease and all dialysis modalities. Dr. Jaar earned his M.D. from Faculte de Medecine et de Pharmacie of the State University of Haiti. He completed nephrology training at Hopitaux de Paris (Hopital Tenon, Hopital Saint Antoine, Hopital Saint Louis) University of Paris V, France. He subsequently completed an internal medicine residency at Graduate Hospital in Philadelphia and a nephrology fellowship at the Johns Hopkins Hospital, in addition to a post-doctoral fellowship in Epidemiology and a Master in Public Health at the Johns Hopkins Bloomberg School of Public Health. His research interests include epidemiology of chronic kidney disease and end-stage kidney disease, particularly survival in dialysis patients, peripheral arterial disease and environmental risk factors for kidney disease. Dr. Jaar was recognized with the C. Lockard Conley Award 2021 by the American College of Physician Maryland Chapter for contributions to resident education / research and the National Kidney Foundation Garabed Eknoyan Award 2022 for promoting the mission of NKF in making the lives of people with kidney disease better. He is a member of several professional organizations, including the International Society of Nephrology, American Society of Nephrology, National Kidney Foundation, American College of Physicians and the International Society of Peritoneal dialysis. Dr. Jaar is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Calcinosis, Low Potassium Level, and Kidney Transplant.

Samantha Ober, M.D., is an Internal Medicine physician and has been working as a primary care physician in Maryland. She earned her Doctor of Medicine degree from Rosalind Franklin University - Chicago Medical School in North Chicago, Illinois, and completed her internal medicine residency at George Washington University Hospital in Washington, D.C. Dr. Ober served one additional year as chief resident, during which time she was an attending physician and educator for medical students and residents. She values building relationships with her patients in order to provide them with the specialized care they need. She strives to educate, empower, and work as a team with patients towards better health. Dr. Ober lives in the Canton neighborhood of Baltimore with her husband, two children and two cats. Dr. Ober is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Vitamin D Deficiency, Familial Hypocalciuric Hypercalcemia Type 1, Hypercalcemia, and Milk-Alkali Syndrome.

Dr. Ronadip (Ron) Banerjee is an Associate Professor in the Division of Endocrinology, Diabetes and Metabolism at Johns Hopkins University School of Medicine. His clinical interests include Endocrine Tumors, such as Multiple Endocrine Neoplasia, adrenal tumors and disorders, pancreatic and neuroendocrine tumors, pituitary, thyroid and parathyroid disorders. Dr. Banerjee received his B.S. in Biological Sciences with. Dr. Banerjee is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. His top areas of expertise are Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Gestational Diabetes, and Hypogonadism.

Dr. Luis F. Gimenez is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise includes nephrology. Dr. Gimenez received his medical degree from Facultad de Medicina de la Universidad de Chile. He completed residencies in internal medicine at Hospital Clinico Regional Dr. Guillermo Grant Benavente, Hospital Carlos Van Buren and the Johns Hopkins School of Medicine. He performed his fellowship in nephrology at Johns Hopkins. His research interests include the pathophysiology of chronic renal failure. Dr. Gimenez is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Minimal Change Disease.

Anita Pasumarthy is a Nephrologist in Baltimore, Maryland. Dr. Pasumarthy is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease.

Novia Singh is a Nephrologist in Baltimore, Maryland. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are End-Stage Renal Disease (ESRD), Nephrosclerosis, Renovascular Hypertension, and Chronic Kidney Disease.

Dr. Rachel M. Kruzan is an instructor of medicine at the Johns Hopkins University School of Medicine. Her area of clinical expertise is internal medicine. Dr. Kruzan earned her M.D. from Rush Medical College. She completed her residency at Johns Hopkins Bayview Medical Center. She has been recognized by the Johns Hopkins Institutions Diversity Leadership Council with a Diversity Recognition Award. Dr. Kruzan is rated as an Experienced provider by MediFind in the treatment of Milk-Alkali Syndrome. Her top areas of expertise are Diabetic Neuropathy, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Familial Hypertension.